San Diego: The Future of AD—Can We Vaccinate?
Scientists are developing better ways to predict who will develop Alzheimer’s disease...
6381 RESULTS
Sort By:
Scientists are developing better ways to predict who will develop Alzheimer’s disease...
Who says Alzheimer's drug development is all Aβ all the time?...
Progranulin mutations cause some forms of frontotemporal dementia, but exactly what the protein does and how it fails in disease are open questions...
Mutations in SOD1, which lead to ALS, cause SOD1 to buddy up with mitochondrial proteins and interfere with normal mitochondrial conductance...
The National Alzheimer’s Project Act could be signed into law just in time for Christmas...
Progress has been slow for researchers toiling to discern the physical makeup of Aβ oligomers, widely seen as the form of amyloid-β most dangerous in AD...
Since the approval of cholinesterase inhibitors and memantine, no new therapy for Alzheimer’s disease has passed the clinical trial litmus test...
The Alzheimer Research Forum and Prize4Life, Inc. are proud to announce the launch of ALSGene, an online field synopsis of genetic association studies in ALS...
In Alzheimer’s disease and other neurodegenerative disorders, misfolded proteins are seen banding together en masse, wreaking havoc in neurons...
Concerned about the dismal National Institute on Aging (NIA) payline expected for next year?...
Alzheimer’s disease patients show reduced rates of Aβ clearance, yet normal Aβ production...
Repairing severed or severely damaged spinal cords is an intractable medical problem, and progress in solving it has been slow...
Spinal cord injury creates a rift that has proven extremely difficult to bridge...
Evidence for cholesterol’s role in Alzheimer’s disease has been growing in recent years, and many cardiovascular risk factors have popped up also...
At SfN, several presentations and posters focused on links between synapse health and apolipoprotein E (ApoE), a major risk factor for late-onset AD...